1. LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target

Volume 21, Issue 5, May 2020, Pages 1453-1458

khaldon Bodoor; Rowida Almomani; Mohammad Alqudah; Yazan Haddad; Walaa Samouri

• View Article
• PDF 1.37 MB

2. Correlation between HER2 Expression and Clinicopathological Features of Breast Cancer: A Cross- Sectional Study in Vietnam

Volume 21, Issue 4, April 2020, Pages 1135-1142

Thuan Dang Cong; Tung Nguyen Thanh; Quynh Anh Nguyen Phan; Ai Phuong Hoang Thi; Bao Song Nguyen Tran; Quoc Huy Nguyen Vu

• View Article
• PDF 634.28 K

3. Subtypes of Breast Cancer in Lao P.D.R.: A Study in a Limited-Resource Setting

Volume 20, Issue 2, February 2019, Pages 589-594

Thitsamay Luangxay; Siriphone Virachith; Kiyomi Hando; Soulideth Vilayvong; Phaengvilay Xaysomphet; Phetsamone Arounlangsy; Keokedthong Phongsavan; Makiko Naka Mieno; Naoko Honma; Masanobu Kitagawa; Motoji Sawabe

• View Article
• PDF 536.47 K

4. Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas

Volume 20, Issue 1, January 2019, Pages 73-79

Nguiessan Alphonse Aman; Brahima Doukoure; Kouadio Donatien Koffi; Baumaney Sylvanus Koui; Zie Cheick Traore; Mohamed Kouyate; Ibrahiman Toure; Ahoua Benjamin Effi

• View Article
• PDF 329.44 K

5. Relationships between Reproductive Risk Factors for Breast Cancer and Tumor Molecular Subtypes

Volume 19, Issue 7, July 2018, Pages 1767-1770

Nahid Nafissi; Maryam Faraji; Mostafa Hosseini; Leyla Shojaee; Fatane Ziaee; Mohamad Esmaiel Akbari; Seyed Hamzeh Mousavie

• View Article
• PDF 269.02 K

6. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India

Volume 19, Issue 5, May 2018, Pages 1381-1385

Asmanaz saleem Nadaf; Hephzibah Rani; Udipi Shastri Dinesh

• View Article
• PDF 746.1 K

7. Epitope mapping of human HER2 specific mouse monoclonal antibodies using recombinant extracellular subdomains of HER2

Volume 18, Issue 11, November 2017, Pages 3103-3110

Reza Hosseini-Ghatar; Tahereh Soltantoyeh; Motahareh Bahadori; Maryam Golara; Hadi Hassannia; Roya Khosravi-Eghbal; Jalal Khoshnoodi; Mohammad Ali Judaki; Forough Golsaz-Shirazi; Mahmood Jeddi-Tehrani; Mohammad Mehdi Amiri; Fazel Shokri

• View Article
• PDF 663.42 K

8. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening

Volume 17, Issue 1, January 2016, Pages 335-339

• View Article
• PDF 389.1 K

9. Relationship between HER2 Proto-oncogene Status and Prognostic Factors of Breast Cancer in the West of Iran

Volume 17, Issue 1, January 2016, Pages 295-298

• View Article
• PDF 390.29 K

10. Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer

Volume 16, Issue 14, December 2015, Pages 5647-5654

• View Article
• PDF 623.68 K

11. Pre-treatment Elevated Platelet Count Associates with HER2 Overexpression and Prognosis in Patients with Breast Cancer

Volume 16, Issue 13, December 2015, Pages 5537-5540

• View Article
• PDF 704.98 K

12. Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines

Volume 16, Issue 14, December 2015, Pages 5977-5981

• View Article
• PDF 491.94 K

13. Recent Progress in HER2 Associated Breast Cancer

Volume 16, Issue 7, July 2015, Pages 2591-2600

• View Article
• PDF 648.62 K

14. Association between GSTP1 Genotypes and Hormone Receptor Phenotype in Invasive Ductal Carcinomas of Breast

Volume 16, Issue 5, May 2015, Pages 1707-1713

• View Article
• PDF 403.96 K

15. Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival

Volume 16, Issue 4, April 2015, Pages 1643-1649

• View Article
• PDF 518.61 K

16. Role of HER2 in Brain Metastasis of Breast Cancer: a Systematic Review and Meta-Analysis

Volume 16, Issue 4, April 2015, Pages 1431-1434

• View Article
• PDF 410.6 K

17. Is Her-2 Status in the Primary Tumor Correlated with Matched Lymph Node Metastases in Patients with Gastric Cancer Undergoing Curative Gastrectomy?

Volume 15, Issue 24, December 2014, Pages 10607-10611

• View Article
• PDF 417.49 K

18. Evaluation of HER-2/neu Overexpression in Gastric Carcinoma using a Tissue Microarray

Volume 15, Issue 18, December 2014, Pages 7597-7602

• View Article
• PDF 483.87 K

19. Immunohistochemistry Subtypes (ER/PR/HER) of Breast Cancer: Where Do We Stand in the West of Saudi Arabia?

Volume 15, Issue 19, December 2014, Pages 8395-8400

• View Article
• PDF 456.67 K

20. New formulated “DOX-MTX-loaded Nanoparticles” Downregulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities

Volume 15, Issue 21, December 2014, Pages 9355-9360

• View Article
• PDF 634.57 K

21. Updated Meta-analysis on HER2 Polymorphisms and Risk of Breast Cancer: Evidence from 32 Studies

Volume 15, Issue 22, December 2014, Pages 9643-9647

• View Article
• PDF 1.28 MB

22. Association of High LDH and Low Glucose Levels in Pleural Space with HER2 Expression in Non-Small Cell Lung Cancer

Volume 15, Issue 4, April 2014, Pages 1617-1620

• View Article
• PDF 318.31 K

23. Higher Ki67 Expression is Associates With Unfavorable Prognostic Factors and Shorter Survival in Breast Cancer

Volume 15, Issue 3, March 2014, Pages 1381-1385

• View Article
• PDF 464.86 K

24. Curcumin and its Analogues (PGV-0 and PGV-1) Enhance Sensitivity of Resistant MCF-7 Cells to Doxorubicin through Inhibition of HER2 and NF-kB Activation

Volume 15, Issue 1, January 2014, Pages 179-184

• View Article
• PDF 1.2 MB

25. Determination of HER2 Gene Amplification in Breast Cancer using Dual-color Silver Enhanced in situ Hybridization (dc- SISH) and Comparison with Fluorescence ISH (FISH)

Volume 14, Issue 10, October 2013, Pages 6131-6134

• View Article
• PDF 676.74 K